ArticleJournal of diabetes investigation2018

Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus.

Francis J Wilbrink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.